After a small setback on Thursday at the opening, the U.S. markets have closed up. The Dow Jones gained 0.10% and the Nasdaq was ahead 0.56%.

This turnaround was due inter alia to the banking shares, despite concerns related to the Greek deficit. Investors were no doubt reassured by the president's Barack Obama who has advocated the adoption in Congress to reform U.S. financial regulation to avoid a crisis similar to that of 2008. And, when Wall Street was shaken by the scandal Goldman Sachs. Goldman Sachs gained 0.09% to 159.08 dollars, Morgan Stanley is up 0.73% to 31.91 dollars. However, JP Morgan Chase 1.34% yield to 44.79 dollars.

The bill provides for the creation of an agency for the protection of consumer financial (CFPA) in the central bank (Fed).It offers a better supervision of the huge derivatives market. The sponsors also seek to end the bailouts of major financial institutions in difficulty at the expense of taxpayers.

From the side of the other values, the Starbucks group (7.33% to 27.25 U.S. dollars) has announced a profit after the close of 217.3 million, or 28 cents per share against 25 cents a share. Revenues climbed 9% to 2.5 billion dollars.

Also note eBay announced a profit of $ 398 million (+11%) and annual sales increased 9% to $ 2.2 billion fast cash loans. "After an outstanding fourth quarter, and a good first quarter, the group is very cautious on the prospects for sale" note the experts at Aurel BGC.The track lost 5.74% to 24.78 dollars.

Also in the technology sector, Apple on Wednesday unveiled the results well above expectations steals record after record. The title of the Apple brand has finished on a new historic high of nearly $ 260 per title. Some rumors suggest that Apple might be interested in undertaking MRA. Apple is the biggest customer of ARM and with the launch of the iPad, the Apple brand would have control over the production of chips. The transaction could reach $ 6 billion. The title gained 2.75% to 266.36 dollars.

The health sector is suffering. The market is increasing concern over the impact of U.S. health reform.Consequence: Merck loses 2.73% to 33.79 dollars, Pfizer was down 0.72% to 16.48 dollars or abandons Johnson & Johnson 0.92% to 64.79 dollars.

In the foreign exchange market remains concerned by the problem of debt Greek, the euro is falling against the dollar Thursday. Around 16 hours, the euro is worth 1.3301 dollars (-0.64%).



Comments are closed.